Tag: Cancer

New England Cancer Specialists will soon offer scalp-cooling technology to help reduce hair loss in cancer patients

By Chiara Battelli MD, President & Lead Physician at New England Cancer Specialists

A cancer diagnosis can change many things about our lives. As patients move forward with their doctor to examine treatment options, one of the major concerns they express is hair loss associated with chemotherapy. Unfortunately, it is hard to predict who will lose their hair even though it is a common and significant side effect of cytotoxic chemotherapy. Studies have shown that hair loss during cancer treatment can lead to lower self-esteem and feelings of depression, ultimately causing up to 10% of patients to forego chemotherapy.

Chemotherapy drugs damage hair follicles in a variety of ways: some drugs cause hair thinning or hair loss only on the scalp, while others can cause hair to thin or fall out on the arms, legs, underarms, eyebrows, or eyelashes. If a person is going to lose hair during treatment, it

Read More

New technology allows cancer patients to watch movies during radiation

AURORA, Colo. (KDVR) — No matter the age, radiation treatment can be tough on any cancer patient. Which is why UCHealth helped develop a special piece of technology to help reduce anxiety and stress associated with it.

The technology is called RadFlix and it allows patients to safely watch their favorite TV shows and movies all while undergoing radiation.

“This can be a very traumatic experience for these kids,” said Dr. Douglas Holt, the Chief Resident radiation oncologist with the University of Colorado Cancer Center.

Holt helped develop the device. It’s a radiation compatible, video distraction system that can be used with any type of radiation treatment.

“That’s important because it’s very technically challenging to do that in radiation,” Holt said.

Not only is it convenient for a patient to watch TV or a movie on RadFlix while undergoing radiation therapy, but it also helps them cut down on the

Read More

New technology at Boca Raton Regional Hospital helps find breast cancer earlier

BOCA RATON, Fla. — Doctors at the Christine E. Lynne Women’s Health & Wellness Institute at Boca Raton Regional Hospital have been using new technology to help spot breast cancer sooner.

The new mammogram technology is called ProFound AI.

“It is artificial intelligence,” Dr. Kathy Schilling said.

Schilling said the AI helps ready the mammograms and can identify cancer by comparing the scans to thousands of others in a database.

“It learns different patterns that are common in cancers,” she added.

The AI has helped the medial team spot suspicious areas in scans they may have missed. Schilling shows a scan with a highlighted area from the AI that she said may have gone overlooked because it was small.

ProFound AI helps spot breast cancer sooner

Miranda Christian/WPTV

New mammogram technology called ProFound AI can help identify breast cancer sooner.

“You don’t have to wait until it gets this big because sometimes it is too late,” breast

Read More

Girls in Tech Teams with McKesson to Hack Against Breast Cancer for October’s Breast Cancer Awareness Month

Winners Receive Cash Prizes for Creating Solutions for Patients, Survivors, and Caregivers Impacted by Breast Cancer

SAN FRANCISCO, Oct. 1, 2020 /PRNewswire/ — Girls in Tech, a global non-profit bringing the world together through education and experiences, is teaming up with McKesson, a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions, for a global hackathon to design innovative solutions for those impacted by breast cancer. The hackathon will help create solutions for patients, survivors, and caregivers. 

(PRNewsfoto/Girls in Tech)
(PRNewsfoto/Girls in Tech)

McKesson will work with Girls in Tech Hackathon winners to utilize solutions as a mobile platform for the McKesson Cause Network, a collection of McKesson employees who are interested in networking and sharing information and resources to help those who have been touched by cancer.

“It’s a priority for Girls in Tech to raise awareness for breast cancer by

Read More

Metro Health adds robotic technology for early lung cancer detection

WYOMING, MI — Metro Health – University of Michigan Health, as a part of the Cancer Network of West Michigan, is pioneering the use of robotic technology to diagnose lung cancer earlier.

The Grand Rapids-area health system’s use of the West Michigan’s first Ion robotic-assisted bronchoscopy tool will help diagnose lung cancer at the earliest, hardest-to-reach stages, according to news release Wednesday announcing the technology.

Health officials expect this new tool to improve hope for survival from lung cancer, the No. 1 cause of cancer death.

“Historically, most lung cancer diagnoses were late,” said Dr. Mounir Ghali, director of Interventional Pulmonology at Metro Health. “When we are able to detect, diagnose and treat sooner, we can help a patient outlive the cancer.”

Ghali is equipped, since Sept. 21, with the world’s most advanced tool for fast, safe and accurate diagnosis, according to Dr. Peter Hahn, president and CEO of Metro

Read More

Scientists plan new groundbreaking facility to transform UK cancer treatment

Scientists plan new groundbreaking facility to transform UK cancer treatment
Credit: Imperial College London

Researchers have unveiled designs for a facility intended to make cheaper, more flexible proton beam therapy for cancer treatment a reality.

Clinicians, biologists, physicists, accelerator scientists and other specialists, including those from Imperial College London, are pooling their expertise to design the pioneering radiobiology facility.

The unique collaboration has resulted in a proposal for a Laser-hybrid Accelerator for Radiobiological Applications (LhARA), which aims to investigate how radiation from a proton beam interacts with biological matter when it is used to kill cancer cells, by using a new approach based on high-power lasers.

The facility would also act as a testbed for new machines that would deliver faster and more effective radiotherapy to cancer patients with reduced side effects.

The proposal for the facility is published in Frontiers in Physics: Medical Physics and Imaging.

Targeting tumors

Professor Ken Long, from the Department of Physics at Imperial

Read More

Qualtrics Raises $25 Million-Plus For Cancer Research Through NBA Jersey Sponsorship

When enterprise software firm Qualtrics decided to join the NBA’s “patch” sponsorship program, cofounder and CEO Ryan Smith immediately saw the marketing power of a 2 1/2 inch square piece of real estate on the jerseys of pro players. A huge basketball fan and Provo native, the 42-year-old jumped at the chance to partner with the Utah Jazz on the program.

But instead of using the company logo to emblazon the shirts, he turned to Qualtrics’ charity arm, 5 For The Fight, which asks people to donate $5 in the fight against cancer. As Smith was evaluating the advantages of the promotion for raising awareness for Qualtrics, one of his executives and cofounder of the 5 For the Fight Foundation, Mike Maughan, asked Smith if he was “all in”

Read More

Cancer Screening Technology Market 2020 – Industry Size, Share, Dynamics, Manufacturer, Status, Outlook and Opportunities: 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 17, 2020 (Profound via COMTEX) —
A recent report provides crucial insights along with application based and forecast information in the Global Cancer Screening Technology Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Cancer Screening Technology market.

With increasing cases of obesity all over the globe, a need for conducting an in-depth study about this healthcare issue led to the development of this report. Increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress, are key market drivers. The report discusses more information about these subjects, with a focus on the rising need for Cancer Screening Technology.

Download Sample –

Read More

Drexel Medicine Researchers Develop New Technology to Target DNA Damage Repair in Cancer Patients | Now


Drexel Medicine Researchers Develop New Technology to Target DNA Damage Repair in Cancer Patients

DNA break

A team of Drexel University College of Medicine researchers is advancing a way to destroy cancer cells exploiting “synthetic lethality,” which is caused by deficiency in the DNA damage response (DDR) pathway. Synthetic lethality occurs when deficiencies in each of any two genes can be tolerated by the cell but the combination of these two deficiencies is lethal.

When a cell cannot repair its DNA effectively, it can lead to the onset or growth of cancer in the body. Seeing this breakdown, a team of Drexel University College of Medicine researchers is advancing a way to destroy cancer cells exploiting “synthetic lethality,” which is caused by deficiency in the DNA damage response (DDR) pathway. Synthetic lethality occurs when deficiencies in each of any two genes can be tolerated by the cell but the combination of

Read More

UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance

Cell culture and plasmids

The human bronchial epithelioid cell line HBE, HEK293T, SMCC-7721, HeLa, and all human lung cancer cell lines including A549, H1299, H292, HCC827, and H1975 cells were purchased from American Type Culture Collection and cultured in RPMI1640 or DMEM with 10% FBS in incubator at 37 °C with 5% CO2. All plasmids were subcloned into entry vector and then transferred to destination vector with indicated Myc, HA, SFB, or GST tag for the expression using Gateway Technology (Invitrogen). K46R mutation was generated by the KOD Hot Start DNA Polymerase (Novagen) and validated by DNA sequencing.

Antibodies and reagents

Anti-UBE2O antibody (GTX119315) for immunohistochemical (IHC) analysis was purchased from GeneTex. Anti-UBE2O antibody (A301-873A) for immunoblotting was purchased from Bethyl Laboratories. Anti-Mxi1 antibody (HPA035319), anti-Flag antibody (F1804), and Cycloheximide (01810) were purchased from Sigma-Aldrich. Anti-Myc (sc-40) and anti-Mxi1 (sc-1042) antibodies were obtained from Santa Cruz Biotechnology. Anti-GAPDH

Read More